LSTA Q4 2018 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-5.51

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$171,923

Balance Sheet

Total Assets

$45M

Total Liabilities

$7M

Stockholders' Equity

$38M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2,000	-100.0%
Gross Profit	$0	$1,000	-100.0%
Operating Income	-$4M	-$7M	+48.1%
Net Income	-$4M	-$3M	-24.3%